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ABSTRACT Conformational energy calculations have been presented on guanine nucleoside in which the furanose ring is
replaced by 2,3-dideoxy-2,3-didehydrofuran using molecular mechanics and conformational analysis. Conformational
energies have been evaluated using the MM2 and AMBER94 force field parameters at two different dielectric constants. The
results are presented in terms of isoenergy contours in the conformational space of the glycosidic () and C4-C5 () bonds
torsions. In general, the - interrelationships differ from the corresponding plots for unmodified nucleosides and nucleotides,
reported previously. Consistency of the calculated preferred conformations with the x-ray data is sensitive to the force field
employed.
INTRODUCTION
Modified nucleosides with both purine and pyrimidine
bases have been the subject of many recent investigations as
potential antiviral agents (Chu et al., 1988; Dytakina et al.,
1994; Andrei et al., 1995; McGuigan et al., 1996a, b;
Eriksson et al., 1991; Bolon et al., 1996). In this light,
extensive structure-activity relationships (SAR) and phar-
macological profiles of modified nucleosides as anti-HIV
agents, inhibitors of hepatitis B virus replication, adenylate
cyclase inhibitors, antitumor agents, etc. have been reported
(Herdewijn et al., 1988; Chu et al., 1989; Robins et al.,
1995; Harte et al., 1991; Bhattacharya et al., 1995; Smee et
al., 1995). Some modified nucleosides (e.g., 2,3-dideoxy-
2,3-didehydrothymidine; D4T) have unique biological
properties rendering them less toxic than AZT and hence
viable candidates for clinical trials as anti-HIV agents
(Hitchcock, 1991; Genu-Dellac et al., 1991). Pharmacoki-
netic studies on D4T have shown that this compound is well
absorbed and is predominantly eliminated unchanged, in
addition to having penetration into the blood-brain barrier in
mice (Russell et al., 1989). A few x-ray crystallographic and
theoretical studies have been reported on such modified
nucleosides (Van Roey and Chu, 1992; Van Roey et al.,
1993; O’Leary and Kishi, 1994; Galisteo et al., 1995, 1996;
Cody and Kalman, 1992; Everaert et al., 1993a, b; Rao,
1995).
In continuation of a study on the structural and confor-
mational aspects of furanose modified nucleosides (Rao,
1995), this paper has investigated conformational prefer-
ences in 2,3-dideoxy-2,3-didehydroguanidine, D4G.
Specifically, molecular mechanics energy evaluation and
refinement have been carried out in the conformational
space of the glycosidic () and C4-C5 () bond torsions
using MM2 and AMBER94 force field parameters. In sim-
ulations with the MM2 force field, two different charge
models were employed, while AMBER94 calculations were
carried out using quantum chemically derived charges. The
qualitative consistency of the calculated low energy models
with the limited single crystal x-ray data on D4G is sensitive
to the force field and the charge model used.
METHODS
Preliminary models of 1 (illustrated below schematically) were built using
MacroModel (v5.0) and energy refined with the MM2 force field
(Mohmadi et al., 1990). The nomenclature adopted for describing the atom
names and torsion angles is as described earlier (Rao, 1995; 1998). Mul-
tiple conformations of 1 were generated by varying the torsions  (O1-
C1-N9-C8) and  (C3-C4-C5-O5) (illustrated below) at 10° interval.
The resultant collections of 1296 conformations were energy refined using
the BatchMin module (Mohamadi et al., 1990) by varying all degrees of
freedom except for  and . These torsions were constrained to their
starting values with a weight of 1000 kcal/mol-degree. Simulations were
carried out using both the MM2 and AMBER94 (Cornell et al., 1995) force
fields.
In the case of simulations with MM2 force field, two charge models were
used. The first one corresponded to partial atomic charges fitted to the
quantum chemically derived electrostatic potentials (vide infra), while the
second model corresponded to charges derived from the MM2 force field,
based on bond dipoles (Mohamadi et al., 1990). The quantum chemically
derived partial atomic charges on the atoms of 1 (Appendix) were obtained
by fitting to the ab initio electrostatic potential surfaces (calculated using
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Gaussian94 (Frisch et al., 1995) with the RHF/6–31G* basis sets). Two
values of dielectric, 1 and 4, were employed in the calculations. These
dielectric values have been previously used by numerous theoretical in-
vestigations on the structure and conformations of nucleic acid constituents
and the results obtained therein are qualitatively consistent with experi-
mental data (Saenger, 1984). In addition to the vacuum simulations,
calculations have also been carried out using the implicit water solvation
model (GBSA) obtained within MacroModel (Mohamadi et al., 1990).
These calculations were done using the quantum chemically derived
charges at a dielectric of 1.
The results of the conformational energy calculations on 1 are shown in
terms of energy plots in the (,) space, wherein isoenergy contours (1
through 5 kcal/mol) are drawn at 1 kcal/mol intervals (Figs. 1–8). Of these,
Figs. 1–4 correspond to energy calculations done with the quantum chem-
ically derived charges, while Figs. 5 and 6 correspond to charges derived
from the MM2 force field. Results of calculations incorporating implicit
solvation are illustrated in the isoenergy contour plots of Figs. 7 and 8,
corresponding to the MM2 and the AMBER94 force fields. In all these
plots, the thickest contour corresponds to 1 kcal/mol relative to global
minimum and the relative energy value increases as the thickness de-
creases. Thus the thinnest contour corresponds to 5 kcal/mol. The energy
minima are listed in Tables 1–6. Only the global minima are marked by
dark solid squares (f) in the (,) maps.
RESULTS
Fig. 1 illustrates the conformational energy plot of 1 in its
(,) space for the dielectric constant of 1.0 and MM2 force
field. The global minimum (M1) is found at (,) 
(40,70°) and corresponds to a structure with anti conforma-
tion of the base and gauche conformation about C4-C5.
The secondary minima obtained in this plot are destabilized
by at least 3 kcal/mol (Table 1). Two of these correspond to
the anti orientation of the base while another to the syn
orientation of the guanine. The 5 kcal/mol energy contour
encloses less than a third of the (,) space.
By contrast, in Fig. 2, which illustrates the conforma-
tional energy plot of 1 for the dielectric constant of 4.0 and
MM2 force field, nearly 80% of the (,) conformational
space is enclosed by the 5 kcal/mol energy contour. In this
plot, the global minimum at (,) (40°,180°) corresponds
to a structure with anti conformation of the base and trans
conformation about C4-C5. Three secondary minima de-
stabilized by 2 kcal/mol relative to the global minimum
are found in the (anti, gauche), (anti, gauche) and (syn,
gauche) regions of the (,) space (Table 2).
The conformational energy plots of 1 corresponding to
the AMBER94 force field at the dielectric constants of 1
and 4 are illustrated in Figs. 3 and 4 with their minima listed
in Tables 3 and 4. In Fig. 3, the global minimum occurs at
(,) (220°,50°) and corresponds to the syn orientation of
the base with a gauche conformation about C4-C5. Only
three secondary minima destabilized by3 kcal/mol (Table
FIGURE 1 Conformational energy map of 1
in the (,) space (dielectric of 1.0 and MM2
force field). Minima are listed in Table 1.
TABLE 1 Energy minima of 1 in the (,) conformational space
(Fig. 1;   1; MM2)
Minimum
Number  (deg)  (deg)
Relative
Energy
(kcal/mol)
1 70.0 40.0 0.00
2 170.0 50.0 3.11
3 50.0 30.0 3.75
4 160.0 160.0 4.72
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3) are found in this plot in which 20% of the conforma-
tional space is enclosed by the 5 kcal/mol energy contour.
As in the case of Fig. 2, this contour encloses a significantly
larger part of the conformational space (60%) in Fig. 4
compared to Fig. 3, where the global minimum still corre-
sponds to the syn orientation of the base with a trans
conformation about C4-C5 (Table 4).
The (,) conformational energy plots in Figs. 5 and 6
corresponding to the dielectric constants of 1 and 4, respec-
tively, and the MM2 charges demonstrate significantly
greater degree of flexibility than the plots in Figs. 1 and 2
and are somewhat similar to those in Figs. 3 and 4. The
global minimum in Fig. 5 occurs for a high syn orientation
of the base (Tables 5 and 6). However, conformations
corresponding to anti orientation of guanine are destabilized
by 0.3 kcal/mol relative to the global minimum. Although
the positions of the secondary minima correspond to the syn
orientation of the base (Table 5), numerous conformations
with anti orientations of the base are feasible in the three
standard ranges of the C4-C5 torsion. The 5 kcal/mol
contour occupies nearly 90% of the total conformational
space.
In the (,) plots computed by including the implicitly
GB/SA solvation model (Figs. 7 and 8), the global minima
correspond to structures with anti orientation of the glyco-
sidic torsion and a trans conformation about C4-C5. This
preference for  can be rationalized on the basis of the fact
that solvation energies are more favorable for extended
structures compared to relatively compact structures, as
would be obtained with gauche conformations. The 5 kcal/
mol contours enclosing the global and secondary minima
(Tables 7 and 8) cover nearly 70% of the (,) conforma-
tional space. This contrasts significantly with the corre-
sponding coverage in the plots corresponding to calculations
without the inclusion of implicit solvation (Figs. 1 and 3).
DISCUSSION
Conformational energy calculations using molecular me-
chanics methods on D4G have been carried out to under-
stand the energetic preferences of the torsions about the
glycosidic and C4-C5 bonds. The results demonstrate sig-
nificant sensitivity to the nature of the force field and the
dielectric used in the simulations. Specifically, these factors
influence the positions of global minima and the barriers to
conformational transitions to secondary minima in the (,)
energy plots. The global minima span four of the possible
six conformational combinations of  and , namely (anti,
gauche), (syn, gauche), (anti, trans) and (syn, trans),
depending upon the force field and dielectric model used.
FIGURE 2 Conformational energy map of
1 in the (,) space (dielectric of 4.0 and
MM2 force field). Minima are listed in Table
2.
TABLE 2 Energy minima of 1 in the (,) conformational space
(Fig. 2;   4; MM2)
Minimum
Number

(deg)

(deg)
Relative
Energy
(kcal/mol)
1 180.0 40.0 0.00
2 50.0 100.0 1.01
3 60.0 40.0 1.28
4 60.0 40.0 1.66
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FIGURE 3 Conformational energy map of
1 in the (,) space (dielectric of 1.0 and
AMBER94 force field). Minima are listed in
Table 3.
FIGURE 4 Conformational energy map of
1 in the (,) space (dielectric of 1.0 and
AMBER force field). Minima are listed in
Table 4.
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Typically, the energy plots calculated with the dielectric of
1.0 tend to demonstrate higher barriers to conformational
transitions compared to those calculated with the dielectric
of 4.0. This effect is more pronounced for the quantum
chemically derived charge model than for the model using
bond dipole derived charges. This leads to the suggestion
that electrostatic forces play a significant role in the deter-
mination of the global and secondary minima, specifically
in models employing quantum chemically derived charges.
For example, the atoms N3, N2, HN2A, and HN2B have
partial atomic charges of 0.81, 1.02, 0.476, and 0.476,
respectively, in the ab initio derived model, while the cor-
responding values are 0.01, 0.68, 0.267, and 0.267 in
the bond dipole derived model obtained from the MM2
force field. Interactions involving these atoms with other
heteroatoms in the molecule will thus tend to dominate
more in the former charge model than in the latter.
It is interesting to note that intramolecular hydrogen
bonding interactions are restricted to those formed between
the C5 hydroxyl group and N3 of the purine. The hydro-
gens of the excocyclic amino group in guanine are located
farther from O5 than required for good hydrogen bonding
distances, by virtue of the lack of puckering in the didehy-
drofuran ring. The energy plots corresponding to the inclu-
sion of an implicit solvation model demonstrate a prefer-
ence for an extended conformation about C4-C5
consistent with increased interaction with an effective sol-
vent environment. In these plots, conformations with syn
orientation of the guanine are destabilized by 2 kcal/mol
relative to those with anti orientation of the purine. This
may be partly due to the relative crowding of the region
around the didehydrofuran by the six-membered ring of the
guanine in the syn orientation while these two rings are
farther apart in the anti orientation, leading to greater sol-
vent accessible surface area than in the former case.
How do the results of these calculations compare with the
available crystal structure information? The limited x-ray
crystallographic studies on D4G (Van Roey and Chu, 1992)
demonstrate glycosidic torsions of 71° and 83° in two
different geometries with gauche conformations about
C4-C5 (  54° and 48°). While the observed (anti,
gauche) conformational combination of the glycosidic and
C4-C5 torsion is not a global minimum in any of the
energy plots, it is a secondary minimum in plots calculated
with implicit solvation and/or a dielectric of 4.0. While anti
FIGURE 5 Conformational energy map of
1 in the (,) space (dielectric of 1.0 and
MM2 force field with MM2 charges). Min-
ima are listed in Table 5.
TABLE 3 Energy minima of 1 in the (,) conformational space
(Fig. 3;   4; AMBER94)
Minimum
Number

(deg)  (deg)
Relative
Energy
(kcal/mol)
1 50.0 140.0 0.00
2 70.0 30.0 3.60
3 160.0 170.0 3.66
TABLE 4 Energy minima of 1 in the (,) conformational space
(Fig. 4;   4; AMBER94)
Minimum
Number  (deg)  (deg)
Relative
Energy
(kcal/mol)
1 170.0 140.0 0.00
2 60.0 140.0 0.73
3 50.0 140.0 0.73
4 170.0 20.0 1.86
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orientation of the base is found in global minima of energy
plots incorporating the implicit GB/SA solvation approach,
these minima demonstrate a trans conformation about C4-
C5. A possible explanation for this discrepancy between
the theoretical models and the x-ray data could lie in the
intermolecular packing interactions present in the x-ray
lattice. Such interactions would be dominated by hydrogen
bonding involving the C5 hydroxyl and the exocyclic
amino and carbonyl groups of the guanine base. Since our
calculations have been done on a single molecule rather
than a lattice, such intermolecular interactions are not ex-
plicitly taken into account. On the other hand, additional
x-ray studies involving D4G and its analogs are in order to
explore the variety of the conformational space accessible to
it, as demonstrated through the present calculations.
Comparing the results of the present calculations with
corresponding ones on guanine ribo and deoxyribonucleo-
sides, reported previously in the literature (Saenger, 1984),
it is found that the unsaturated five-membered ring does not
lead to significant variations in the normal conformational
preferences about the glycosidic (syn and anti) and C4-C5
bonds (gauche and trans). However, their conformational
combinations in the global minima of the nucleosides with
the saturated and unsaturated five-membered rings are dif-
ferent. These preferences are influenced by stronger in-
tramolecular hydrogen bonding (between the exocyclic
amino group of the base with O5) in the saturated com-
pound due to the pseudorotational flexibility of the
furanose. These observations imply that D4G and its ana-
logs could be potentially used as surrogates for guanine
nucleotides in the design of therapeutic agents (e.g., anti-
cancer drugs with a mechanism of action involving nucle-
otide recognition).
CONCLUSION
Conformational energy calculations on 2,3-dideoxy-2,3-
didehydroguanidine using a variety of computational pro-
tocols encompassing force field, charge and dielectric mod-
els indicate that its conformational preferences about the
TABLE 5 Energy minima of 1 in the (,) conformational space
(Fig. 5;   1; MM2) using the MM2 charge model
Minimum
Number  (deg)  (deg)
Relative
Energy
(kcal/mol)
1 50.0 90.0 0.00
2 180.0 160.0 0.13
3 60.0 150.0 0.81
4 70.0 160.0 0.90
TABLE 6 Energy minima of 1 in the (,) conformational space
(Fig. 6;   4; MM2) using the MM2 charge model
Minimum
Number  (deg)  (deg)
Relative
Energy
(kcal/mol)
1 60.0 100.0 0.00
2 180.0 140.0 0.11
3 60.0 140.0 1.46
4 60.0 40.0 1.72
FIGURE 6 Conformational energy map of 1
in the (,) space (dielectric of 4.0 and MM2
force field with MM2 charges). Minima are
listed in Table 6.
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glycosidic and C4-C5 bonds are very sensitive to the pro-
tocol employed. The energy profiles in the (,) conforma-
tional energy plots of this compound are generally similar to
those of the corresponding nucleoside with a flexible
furanose only when the calculations are done with a higher
dielectric constant, independent of the charge model used.
The observed x-ray data on D4G-containing systems are
limited and the glycosidic orientations therein are again
FIGURE 7 Conformational energy map
of 1 in the (,) space (dielectric of 1.0, ab
initio charges, and MM2 force field with
GBSA solvation model). Minima are listed
in Table 7.
FIGURE 8 Conformational energy map
of 1 in the (,) space (dielectric of 1.0, ab
initio charges, and AMBER94 force field
with GBSA solvation model). Minima are
listed in Table 8.
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consistent with either a higher dielectric model or an im-
plicit solvation included model.
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